BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 3062845)

  • 1. Effect of glicentin-related peptides upon the secretion of insulin and glucagon in the canine pancreas.
    Ohneda A; Ohneda M
    Tohoku J Exp Med; 1988 Jun; 155(2):197-204. PubMed ID: 3062845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of glicentin-related peptides on glucagon secretion in anaesthetized dogs.
    Ohneda A; Kobayashi T; Nihei J
    Diabetologia; 1986 Jun; 29(6):397-401. PubMed ID: 3527839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulinotropic action of human glicentin in dogs.
    Ohneda A; Ohneda K; Nagasaki T; Sasaki K
    Metabolism; 1995 Jan; 44(1):47-51. PubMed ID: 7854165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of C-terminal fragments of glucagon on insulin secretion in dogs.
    Ohneda A; Ohneda K
    Metabolism; 1994 Jun; 43(6):771-5. PubMed ID: 8201969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The structure-function relationship of GLP-1 related peptides in the endocrine function of the canine pancreas.
    Ohneda A; Ohneda K; Ohneda M; Koizumi F; Ohashi S; Kawai K; Suzuki S
    Tohoku J Exp Med; 1991 Nov; 165(3):209-21. PubMed ID: 1807008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin releasing action of N-terminal peptides of glucagon in dogs.
    Ohneda A; Ohneda K; Koizumi F
    Tohoku J Exp Med; 1992 Aug; 167(4):287-95. PubMed ID: 1488751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of growth hormone on acute glucagon and insulin release.
    Sirek A; Vranic M; Sirek OV; Vigas M; Policova Z
    Am J Physiol; 1979 Aug; 237(2):E107-12. PubMed ID: 380363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon secretory responses to insulin-induced hypoglycemia and arginine in streptozotocin-induced diabetic dogs.
    Gotoh M; Okamura J; Monden M; Shima K
    Endocrinol Jpn; 1983 Aug; 30(4):443-50. PubMed ID: 6368206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of intraluminal administration of amino acids upon plasma glicentin.
    Ohneda A; Kobayashi T; Nihei J; Takahashi H
    Diabetes Res Clin Pract; 1988 Oct; 5(4):265-70. PubMed ID: 3069408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Ca antagonists, nifedipine, niludipine and verapamil, on endocrine function of the pancreas.
    Ohneda A; Kobayashi T; Nihei J
    Tohoku J Exp Med; 1983 Jun; 140(2):153-9. PubMed ID: 6351351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disopyramide induces insulin secretion and plasma glucose diminution: studies using the in situ canine pancreas.
    Nakabayashi H; Ito T; Igawa T; Hiraiwa Y; Imamura T; Seta T; Kawato M; Usukura N; Takeda R
    Metabolism; 1989 Feb; 38(2):179-83. PubMed ID: 2643753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the effects of arginine and glucose on glucagon and insulin release from the perfused rat pancreas.
    Gerich JE; Charles MA; Grodsky GM
    J Clin Invest; 1974 Oct; 54(4):833-41. PubMed ID: 4430717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response of plasma glicentin to fat ingestion in piglets.
    Ohneda A; Takahashi H; Maruyama Y
    Diabetes Res Clin Pract; 1987; 3(2):103-9. PubMed ID: 3552536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biochemical characterization of proglucagon-related peptides.
    Yanaihara N; Mochizuki T; Satoh T; Imai S; Sasaki K; Kakuyama H; Hosoe H; Takatsuka N; Iguchi K; Luo WQ; Kurokawa N; Yanaihara C
    Ann N Y Acad Sci; 1996 Dec; 805():20-9; discussion 29-30. PubMed ID: 8993390
    [No Abstract]   [Full Text] [Related]  

  • 15. [In vitro and in vivo effect of gold thioglucose on the insulin- and glucagon-secretion of the isolated perfused rat pancreas].
    Blech W; Bierwolf B; Weiss I; Ziegler M
    Biomed Biochim Acta; 1986; 45(4):507-22. PubMed ID: 3085662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagon release induced by pancreatic nerve stimulation in the dog.
    Marliss EB; Girardier L; Seydoux J; Wollheim CB; Kanazawa Y; Orci L; Renold AE; Porte D
    J Clin Invest; 1973 May; 52(5):1246-59. PubMed ID: 4349486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Calcium and endocrine pancreas secretion. I. Effects of an infusion of calcium on plasma levels of insulin and glucagon].
    Cucinotta D; Quartarone M; Saitta A; De Pasquale R; Perdichizzi G; Squadrito G
    Boll Soc Ital Biol Sper; 1980 Feb; 56(4):332-8. PubMed ID: 7018517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanism of vagal nerve stimulation of glucagon and insulin secretion in the dog.
    Ahrén B; Taborsky GJ
    Endocrinology; 1986 Apr; 118(4):1551-7. PubMed ID: 3512257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of somatostatin inhibition of insulin and glucagon secretion.
    Bhathena SJ; Perrino PV; Voyles NR; Smith SS; Wilkins SD; Coy DH; Schally AV; Recant L
    Diabetes; 1976 Nov; 25(11):1031-40. PubMed ID: 992224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic effects of graded glucagon infusions in man: inhibition of glucagon, insulin, and somatostatin response to arginine.
    Pontiroli AE; Perfetti MG; Andreotti AC; Fattor B; Monti LD; Pozza G
    Metabolism; 1993 Oct; 42(10):1242-8. PubMed ID: 8105365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.